Ditchcarbon
  • Customers
  1. Organizations
  2. Ardelyx, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 5 months ago

Ardelyx, Inc.

Company website

Ardelyx, Inc., a biopharmaceutical company headquartered in the United States, is dedicated to developing innovative therapies for patients with gastrointestinal and renal diseases. Founded in 2007, Ardelyx has made significant strides in the industry, particularly with its focus on unique mechanisms of action that address unmet medical needs. The company’s flagship product, tenapanor, is designed to treat conditions such as irritable bowel syndrome with constipation (IBS-C) and hyperphosphataemia in patients with chronic kidney disease. Ardelyx's commitment to scientific excellence and patient-centric solutions has positioned it as a notable player in the biopharmaceutical landscape. With a robust pipeline and a focus on advancing healthcare, Ardelyx continues to make impactful contributions to the industry.

DitchCarbon Score

How does Ardelyx, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Ardelyx, Inc.'s score of 25 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.

30%

Let us know if this data was useful to you

Ardelyx, Inc.'s reported carbon emissions

Ardelyx, Inc., headquartered in the US, currently does not have available carbon emissions data for the most recent year, nor does it report any specific reduction targets or initiatives. The company has not disclosed any commitments to the Science Based Targets initiative (SBTi) or other climate pledges. As such, there are no specific figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions. In the absence of concrete emissions data or reduction commitments, Ardelyx, Inc. appears to be in the early stages of addressing climate-related issues within its operations. The lack of reported data may reflect a broader industry context where many companies are still developing their sustainability strategies.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Ardelyx, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Ardelyx, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Ardelyx, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Boehringer Ingelheim Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Sucampo Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Ironwood Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Quanta Dialysis Technologies Limited

GB
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 13 days ago

JMS Co.,Ltd.

JP
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 13 days ago

Fresenius Medical Care Holdings, Inc.

US
•
Health and social work services (85)
Updated 9 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250807.8
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy